디피니엄 테라퓨틱스
DFTX · 최근 20건
15
매수
5
매도
−$1.3M
순매수
거래 내역
Barrow Robert
Chief Executive Officer · 2026. 8. 12.
+
매수
Roberts Brandi
Chief Financial Officer · 2026. 8. 12.
+
매수
Wiley Matthew T.
Chief Commercial Officer · 2026. 8. 12.
+
매수
Sullivan Mark
Chief Legal Officer · 2026. 8. 12.
+
매수
Karlin Daniel
Chief Medical Officer · 2026. 8. 12.
+
매수
Barrow Robert
Chief Executive Officer · 2026. 6. 25.
−$1.3M
매도
Roberts Brandi
Chief Financial Officer · 2026. 6. 25.
−$136K
매도
Karlin Daniel
Chief Medical Officer · 2026. 6. 25.
−$452K
매도
Wiley Matthew T.
Chief Commercial Officer · 2026. 6. 25.
−$129K
매도
Sullivan Mark
Chief Legal Officer · 2026. 6. 25.
−$586K
매도
Barrow Robert
Chief Executive Officer · 2026. 6. 22.
+
매수
Wiley Matthew T.
Chief Commercial Officer · 2026. 6. 22.
+
매수
Roberts Brandi
Chief Financial Officer · 2026. 6. 22.
+
매수
Sullivan Mark
Chief Legal Officer · 2026. 6. 22.
+
매수
Karlin Daniel
Chief Medical Officer · 2026. 6. 22.
+
매수
Bruhn Suzanne Louise
Director · 2026. 6. 11.
+
매수
Bruhn Suzanne Louise
Director · 2026. 6. 11.
+$463K
매수
Adsett Roger
Director · 2026. 6. 11.
+$352K
매수
Adsett Roger
Director · 2026. 6. 11.
+
매수
Krebs Andreas
Director · 2026. 6. 11.
+$463K
매수